期刊文献+

内异症患者性激素受体与基质金属蛋白酶抑制剂-1表达的研究

Expression of ER, PR and TIMP-1 in patients with the endometriosis
下载PDF
导出
摘要 目的检测ER、PR和TIMP-1在子宫内膜异位症(EMs)患者的异位内膜和在位内膜中表达,探讨三者在内异症发生发展中的作用。方法采用免疫组织化学PV-9000法分别检测ER、PR和TIMP-1的表达。研究组:84例EMs的异位内膜和44例在位内膜;对照组:32例子宫肌瘤者正常子宫内膜。结果异位内膜组织中ER、PR及TIMP-1的表达明显低于正常内膜组织,差异均有统计学意义(P<0.01,P<0.05);在位内膜组织ER、PR却明显高于正常内膜组织,差异亦均有显著性(P<0.05),而TIMP-1在在位内膜中呈低表达,与正常内膜组织中的表达相比有统计学意义(P<0.05)。结论ER、PR、TIMP-1在异位内膜和子宫内膜异位症在位内膜中的异常表达,可能与内异症的发生发展有关。 Objective To detect the expression of ER, PR and TIMP-1 in the ectopic endometrium and eutopic endometrium in the patients with endometriosis and investigate the role of ER, PR and TIMP-1 in pathogenesis of the endometriosis. Methods The immunohistochemistry PV-9000 was used for detection of ER, PR and TIMP-1. In the research group, there were 84 cases of eetopic endometrium and 44 cases of eutopic endometrium of EMs while in the control group there were 32 cases of normal endometrium of patients with uterine myoma. Results The expression of ER and PR was significantly lower in the ectopic endometrium than in the normal endometrium (P〈0.01 and P〈0.05). The expression of ER, PR and TIMP-1 was significantly higher in the eutopic en- dometrium than in the normal endometrium (P〈0.05) while the expression of TIMP-1 was lower in the eutopic endometrium than in the normal endometrium (P〈0.05).Gonclusion The abnormal expression of ER, PR and TIMP-1 in the eutopic endometrium and the eutopic endometrium of the endometriosis may be related to the pathogenesis of endometriosis.
出处 《中国疗养医学》 2008年第2期71-73,共3页 Chinese Journal of Convalescent Medicine
关键词 子宫内膜异位症 性激素受体 基质金属蛋白酶抑制剂 免疫组织化学 Endometriosis Sex hormone receptor Tissue inhibitors of metalloproteinase Immunohistochemisty
  • 相关文献

参考文献8

  • 1Amy R, Barlara, Mace L, et al. Matrisian : matris metalloproteinasesc biologic activity and clinical implications [J] .J Clin Oncol, 2000,18 ( 5 ) : 1135
  • 2Collette T, Bellehumeur C, Kats R, et al. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9 [ J ] . Hum Reprod , 2004 , 19 ( 6 ) : 1257-1264
  • 3丁小曼 冷金花.芳香化酶与子宫内膜异位症[A].郎景和.子宫内膜异位症的基础与临床研究[M].北京:北京医科大学\,中国协和医科大学联合出版社,2003.228-242.
  • 4Sillem M, Hahn U, Coddington CC 3rd, Gordon K, Runnebaum B, Hodgen GD. Ectopic growth of endometrium depends on is structural integritu and proteolytic activity in the cynomolgus monkey ( Macaca fascicularis ) model of endometrio sis [ J ]. Fertil Steril, 1998, Sep ; 66 ( 3 ) : 468-73
  • 5郎景和.子宫内膜异位症研究的新里程[J].中华妇产科杂志,2005,40(1):3-4. 被引量:280
  • 6Ramon L, Gilabert-estelles J, Castello R, et al. mRNA analysis of several components of the plas minogen activator nd matrix metalloproteinase systEMs in endometriosis using a real-time puantitative RT-PCR assay [ J ] . Hum Reprod , 2005 , 20 ( 1 ) : 272-278
  • 7孔丽娜,孙青,李书勤,李铁臣,卢林明.子宫内膜异位症中膜型1-基质金属蛋白酶和基质金属蛋白酶组织抑制因子-1表达的研究[J].中国实用妇科与产科杂志,2006,22(5):367-368. 被引量:5
  • 8李艳,郎景和.基质金属蛋白酶9及其组织抑制剂1在子宫内膜异位症组织中的表达[J].中华妇产科杂志,2006,41(1):30-33. 被引量:27

二级参考文献17

  • 1Revised American Society for reproductive Medicine classification of endometriosis:1996.Fertil Steril,1997,67:817-821.
  • 2Lichtinghagen R,Huegel O,Seifert T,et al.Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.Clin Chem,2000,46:183-192.
  • 3Koks CA,Groothuis PG,Slaats P,et al.Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstruum and peritoneal fluid.Fertil Steril,2000,73:604-612.
  • 4Nap AW,Dunselman GA,de Goeij AF,et al.Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model.Hum Reprod,2004,19:2180-2187.
  • 5Chung HW,Lee JY,Moon HS,et al.Matrix metalloproteinase-2,membranous type 1 matrix metalloproteinase,and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium.Fertil Steril,2002,78:787-795.
  • 6Gilabert-Estelles J,Estelles A,Gilabert J,et al.Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis.Hum Reprod,2003,18:1516-1522.
  • 7Mizumoto H,Saito T,Ashihara K,et al.Expression of matrix metalloproteinases in ovarian endometriomas:immunohistochemical study and enzyme immunoassay.Life Sci,2002,71:259-273.
  • 8Huang HF,Hong LH,Tan Y,et al.Matrix metalloproteinase 2is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis[J].Fertil Steril,2004,81(5):1235-1239.
  • 9Ueda M,Yamashita Y,Takehara M,et al.Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis[J].Gynecol Endocrinol,2002,16(5):391-402.
  • 10Henriet P,Cornet PB,Lemoine P,et al.Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs)[J].Ann N Y Acad Sci,2002,955(1):119-138.

共引文献305

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部